Stay updated on ZFN Therapeutic SB-318 in MPS I Clinical Trial
Sign up to get notified when there's something new on the ZFN Therapeutic SB-318 in MPS I Clinical Trial page.

Latest updates to the ZFN Therapeutic SB-318 in MPS I Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page now displays Revision: v3.4.2, and the prior government-funding lapse notice (along with the v3.4.1 revision) has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedAdministrative updates were added: a site-wide notice about a lapse in government funding and a revision to v3.4.1 replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedA new 'Show glossary' option is added, and metadata labels are updated to 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', with capitalization tweaks to 'No FEAR Act Data'. These adjustments affect only UI and metadata and do not change the study details, eligibility criteria, or outcome measures.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a Locations section including California; removed the California Locations entry and the HHS Vulnerability Disclosure; updated the page revision to v3.3.3.SummaryDifference0.2%

- Check85 days agoChange DetectedThe page shows Revision: v3.3.2 replacing v3.3.1, a minor site revision tag that does not affect study content or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to ZFN Therapeutic SB-318 in MPS I Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ZFN Therapeutic SB-318 in MPS I Clinical Trial page.